FGL2 and cancer: FGL2 is an important pleiotropic immunomodulatory cytokine discovered in recent years, which in cancer achieves immunosuppression by inhibiting antigen-presenting cells (APCs), suppressing T cell proliferation, inducing macrophage polarization to M2 and inducing regulatory T cell (TREG) activity (22, 23).